Significant correlation between plasma and CSF anticholinergic activity in presurgical patients.

Standard

Significant correlation between plasma and CSF anticholinergic activity in presurgical patients. / Plaschke, Konstanze; Thomas, Christine; Engelhardt, Ria; Teschendorf, Peter; Hestermann, Ute; Weigand, Markus A; Martin, Eike; Kopitz, Juergen.

In: NEUROSCI LETT, Vol. 417, No. 1, 1, 2007, p. 16-20.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Plaschke, K, Thomas, C, Engelhardt, R, Teschendorf, P, Hestermann, U, Weigand, MA, Martin, E & Kopitz, J 2007, 'Significant correlation between plasma and CSF anticholinergic activity in presurgical patients.', NEUROSCI LETT, vol. 417, no. 1, 1, pp. 16-20. <http://www.ncbi.nlm.nih.gov/pubmed/17350758?dopt=Citation>

APA

Plaschke, K., Thomas, C., Engelhardt, R., Teschendorf, P., Hestermann, U., Weigand, M. A., Martin, E., & Kopitz, J. (2007). Significant correlation between plasma and CSF anticholinergic activity in presurgical patients. NEUROSCI LETT, 417(1), 16-20. [1]. http://www.ncbi.nlm.nih.gov/pubmed/17350758?dopt=Citation

Vancouver

Plaschke K, Thomas C, Engelhardt R, Teschendorf P, Hestermann U, Weigand MA et al. Significant correlation between plasma and CSF anticholinergic activity in presurgical patients. NEUROSCI LETT. 2007;417(1):16-20. 1.

Bibtex

@article{f8f4aed7598e475e9a9e3454978543e1,
title = "Significant correlation between plasma and CSF anticholinergic activity in presurgical patients.",
abstract = "Previous studies have suggested a possible link between cognitive impairment and anticholinergic burden as reflected by high serum anticholinergic activity (SAA). Thus, we hypothesized a close relationship between anticholinergic activity in cerebral spinal fluid (CSF) and blood. However, it has never been convincingly demonstrated that peripheral anticholinergic activity correlates with central anticholinergic levels in presurgical patients. Therefore, anticholinergic activity was measured in blood and CSF from 15 patients with admission scheduled for urological surgery to compare peripheral and central anticholinergic level. Blood and CSF probes were taken after routine premedication and before spinal anesthesia. Anticholinergic activity was determined by competitive radioreceptor binding assay for muscarinergic receptors. Correlation analysis was conducted for peripheral and central anticholinergic levels. The mean anticholinergic levels were 2.4+/-1.7 in the patients' blood and 5.9+/-2.1 pmol/mL of atropine equivalents in CSF. Interestingly, the anticholinergic activity in CSF was about 2.5-fold higher than in patients' blood. A significant linear correlation was detected between blood and CSF levels. Therefore we conclude that SAA levels adequately reflect central anticholinergic activity. When patients receiving or not receiving anticholinergic medication were compared, anticholinergic activity tended to increase in blood and CSF after receiving anticholinergic medication > or =4 weeks (p>0.05).",
author = "Konstanze Plaschke and Christine Thomas and Ria Engelhardt and Peter Teschendorf and Ute Hestermann and Weigand, {Markus A} and Eike Martin and Juergen Kopitz",
year = "2007",
language = "Deutsch",
volume = "417",
pages = "16--20",
journal = "NEUROSCI LETT",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

RIS

TY - JOUR

T1 - Significant correlation between plasma and CSF anticholinergic activity in presurgical patients.

AU - Plaschke, Konstanze

AU - Thomas, Christine

AU - Engelhardt, Ria

AU - Teschendorf, Peter

AU - Hestermann, Ute

AU - Weigand, Markus A

AU - Martin, Eike

AU - Kopitz, Juergen

PY - 2007

Y1 - 2007

N2 - Previous studies have suggested a possible link between cognitive impairment and anticholinergic burden as reflected by high serum anticholinergic activity (SAA). Thus, we hypothesized a close relationship between anticholinergic activity in cerebral spinal fluid (CSF) and blood. However, it has never been convincingly demonstrated that peripheral anticholinergic activity correlates with central anticholinergic levels in presurgical patients. Therefore, anticholinergic activity was measured in blood and CSF from 15 patients with admission scheduled for urological surgery to compare peripheral and central anticholinergic level. Blood and CSF probes were taken after routine premedication and before spinal anesthesia. Anticholinergic activity was determined by competitive radioreceptor binding assay for muscarinergic receptors. Correlation analysis was conducted for peripheral and central anticholinergic levels. The mean anticholinergic levels were 2.4+/-1.7 in the patients' blood and 5.9+/-2.1 pmol/mL of atropine equivalents in CSF. Interestingly, the anticholinergic activity in CSF was about 2.5-fold higher than in patients' blood. A significant linear correlation was detected between blood and CSF levels. Therefore we conclude that SAA levels adequately reflect central anticholinergic activity. When patients receiving or not receiving anticholinergic medication were compared, anticholinergic activity tended to increase in blood and CSF after receiving anticholinergic medication > or =4 weeks (p>0.05).

AB - Previous studies have suggested a possible link between cognitive impairment and anticholinergic burden as reflected by high serum anticholinergic activity (SAA). Thus, we hypothesized a close relationship between anticholinergic activity in cerebral spinal fluid (CSF) and blood. However, it has never been convincingly demonstrated that peripheral anticholinergic activity correlates with central anticholinergic levels in presurgical patients. Therefore, anticholinergic activity was measured in blood and CSF from 15 patients with admission scheduled for urological surgery to compare peripheral and central anticholinergic level. Blood and CSF probes were taken after routine premedication and before spinal anesthesia. Anticholinergic activity was determined by competitive radioreceptor binding assay for muscarinergic receptors. Correlation analysis was conducted for peripheral and central anticholinergic levels. The mean anticholinergic levels were 2.4+/-1.7 in the patients' blood and 5.9+/-2.1 pmol/mL of atropine equivalents in CSF. Interestingly, the anticholinergic activity in CSF was about 2.5-fold higher than in patients' blood. A significant linear correlation was detected between blood and CSF levels. Therefore we conclude that SAA levels adequately reflect central anticholinergic activity. When patients receiving or not receiving anticholinergic medication were compared, anticholinergic activity tended to increase in blood and CSF after receiving anticholinergic medication > or =4 weeks (p>0.05).

M3 - SCORING: Zeitschriftenaufsatz

VL - 417

SP - 16

EP - 20

JO - NEUROSCI LETT

JF - NEUROSCI LETT

SN - 0304-3940

IS - 1

M1 - 1

ER -